Resources | RCPCH

All resources

Our resources and documents include training and career guidance, research and audit reports, policy statements, service standards and online learning. You can use the search or filter to find what you're looking for.

Document

S.A.F.E. Toolkit Module 2 - Theories of patient safety and application to the programme

In our second module, we look at the theories that underpin the development of a patient safety culture, including some tools and techniques for assessing your culture and working to improve it.

Quality improvement

Patient safety

Document

S.A.F.E. Toolkit Module 4 - Team perspectives

S.A.F.E teams have shown how the huddle can enable healthcare professionals to communicate effectively, and recognise and respond to the deteriorating child in a timely way. Once the intervention has been implemented, teams have also evaluated their work. This has allowed them to evidence the succes...

Quality improvement

Patient safety

Resource

Safety-netting information following a first seizure without a fever in children and young people

These high quality leaflets provide information to parents and carers of children and young people who have had a first seizure that was not considered to be a ‘febrile convulsion’, as well as children and young people themselves.

Community child health

Document

Situation Awareness for Everyone (S.A.F.E) toolkit- introduction

How can we reduce preventable deaths and error in children's hospitals? We worked with 50 sites over four years on the S.A.F.E. programme to develop and trial quality improvement techniques. This toolkit supports child health professionals to use these principles at their sites. It can help improve ...

Quality improvement

Patient safety

Resource

Standardising intravenous infusion concentrations in children in the UK

The Neonatal and Paediatric Pharmacy Group (NPPG), with support from the Royal College of Paediatrics of Child Health (RCPCH) has produced a proposal for a national approach for standardised intravenous infusion concentrations in children.

Drugs and medicines

Patient safety

Resource

Statutory Duty of Candour for Northern Ireland - consultation response

In August 2021, we responded to the Department of Health Northern Ireland's proposal for a statutory Duty of Candour and Being Open Framework. The RCPCH broadly welcomes an organisational Duty of Candour, but we believe that an additional, individual Duty would be cumbersome, duplicative, and dispro...

Quality improvement

Patient safety

Workforce

Resource

Suspected side effect from a medicine - how to report

The Medicines and Healthcare products Regulatory Agency (MHRA) “Yellow Card Scheme” is the UK system for collecting and monitoring information on suspected safety concerns or incidents involving side effects from medicines (also known as adverse drug reactions or ADRs) and medical devices.

Drugs and medicines

Patient experience

Patient safety

Document

System-wide Paediatric Observation Tracking (SPOT) Programme - Developing a standardised Paediatric Early Warning System (PEWS) for England

RCPCH is collaborating with NHS England and the Royal College of Nursing to develop a single national PEWS for England. Led by the NHS England Children and Young People’s Transformation Team, the System-wide Paediatric Observations Tracking (SPOT) programme launched in 2020, with a programme of r...

Quality improvement

Patient safety

Resource

Using quality improvement methodology to reduce central line associated blood stream infections - a case study for NNAP

This case study was included in the 2017 National Neonatal Audit Programme annual report to highlight how a neonatal unit has used its results from the National Neonatal Audit Programme as a basis to identify and implement local quality improvement activities. You can download full case study below.

Child and adolescent mortality

Intensive care medicine

Neonatal medicine

Perinatal medicine

Secondary care

Clinical guidelines and standards

Infant

Quality improvement

Resource

Valproate use in women, girls of childbearing years and boys - guidance

This page has updated guidance on the medicine, valproate in accordance with regulation changes from the Medicines & Healthcare products Regulatory Agency (MHRA) in January 2024.

All resources

S.A.F.E. Toolkit Module 2 - Theories of patient safety and application to the programme

S.A.F.E. Toolkit Module 4 - Team perspectives

Safety-netting information following a first seizure without a fever in children and young people

Situation Awareness for Everyone (S.A.F.E) toolkit- introduction

Standardising intravenous infusion concentrations in children in the UK

Statutory Duty of Candour for Northern Ireland - consultation response

Suspected side effect from a medicine - how to report

System-wide Paediatric Observation Tracking (SPOT) Programme - Developing a standardised Paediatric Early Warning System (PEWS) for England

Using quality improvement methodology to reduce central line associated blood stream infections - a case study for NNAP

Valproate use in women, girls of childbearing years and boys - guidance

Filter by resource type

Filter by topic